Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
scavv9.cb.cln6 (1 trial)
Neuronal Ceroid-Lipofuscinoses (Phase 2)
Trials (1 total)
Trial APIs (1 total)